Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 258.74
-1.27 (-0.49%)
At close: Feb 5, 2026
Cochlear Market Cap
Cochlear has a market cap or net worth of 16.92 billion as of February 5, 2026. Its market cap has decreased by -17.09% in one year.
Market Cap
16.92B
Enterprise Value
16.88B
Revenue
2.34B
Ranking
n/a
PE Ratio
43.65
Stock Price
258.74
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 16.92B, an increase of 38,201.33%. That is a compound annual growth rate of 21.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 16.92B | -0.74% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 1.79B |
| Anteris Technologies Global | 812.86M |
| PolyNovo | 670.12M |
| Aroa Biosurgery | 231.47M |
| Lumos Diagnostics Holdings | 206.04M |
| EMVision Medical Devices | 168.22M |
| SomnoMed | 143.08M |
| Cleo Diagnostics | 86.22M |